Evidence map›Paper›PMID 35096995›Full record

ArticleFrontiers in cardiovascular medicine2021

Rivaroxaban Once-Daily vs. Dose-Adjusted Vitamin K Antagonist on Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF): Rationale and Design of an Investigator-Initiated Multicenter Randomized Prospective Open-Labeled Pilot Clinical Study.

Iksung Cho, Jaewon Oh, In-Cheol Kim, Hyemoon Chung, Jung-Hee Lee, Hyue Mee Kim, Young Sup Byun, Byung-Su Yoo, Eui-Young Choi, Wook-Jin Chung and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Iksung ChoCardiology Division, Cardiovascular Research Institute, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Jaewon OhCardiology Division, Cardiovascular Research Institute, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
In-Cheol KimDivision of Cardiology, Keimyung University Dongsan Medical Center, Daegu, South Korea.
Hyemoon ChungDivision of Cardiology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea.
Jung-Hee LeeDivision of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, South Korea.
Hyue Mee KimDivision of Cardiology, Department of Internal Medicine, Chung-Ang University, Seoul, South Korea.
Young Sup ByunDivision of Cardiology, Sanggye-Paik Hospital, Inje University, Seoul, South Korea.
Byung-Su YooDepartment of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea.
Eui-Young ChoiDivision of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Wook-Jin ChungDepartment of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea.
Wook Bum PyunDivision of Cardiology, Department of Internal Medicine, Ewha Womans University, Seoul, South Korea.
Seok-Min KangCardiology Division, Cardiovascular Research Institute, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Yonsei University · KRGangnam Severance Hospital · KRChung-Ang University · KREwha Womans University · KRGachon University Gil Medical Center · KRInje University Sanggye Paik Hospital · KRKeimyung University · KRKyung Hee University · KRYeungnam University Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute decompensated heart failureatrial fibrillationbiomarkerrivaroxabanvitamin K antagonist (VKA)

Identifiers

PMID35096995
PMCPMC8790040
OpenAlexW4210253787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.